Navigation Links
Stem Cell Profits Five Years Away, Says Repair Stem Cell Institute Chairman to The Wall Street Transcript

BANGKOK, Thailand, Sept. 8 /PRNewswire/ -- Don Margolis, Chairman of The Repair Stem Cell Institute LLC (RSCI; based in Bangkok, Thailand told The Wall Street Transcript (TWST) in an exclusive news interview published today that future profits inside the stem cell research sector will be hard to come by over the next five years, even for companies specializing in Repair Stem Cells (often called "adult stem cells"), where new life science discoveries are coming faster than anybody can keep up with. TWST is an international financial news weekly published in New York City ( Highlights from the TWST news interview can be read by visiting the RSCI web site.

According to Mr. Margolis, stem cell research companies that store umbilical cord blood cells for future use will have "the best shot at making the first profits once the public becomes aware how well these stem cells work." The RSCI Chairman is the founder of TheraVitae, the first stem cell company in the world to successfully treat dying heart patients with Repair Stem Cells.

Among the other predictions Mr. Margolis made in this TWST financial news interview were the following:

-- Wall Street has been discounting Embryonic Stem Cell (ESC) company stocks from 2004 through this summer when these stocks hit new lows;

-- There are 2100 Adult Stem Cell clinical trials listed at right now "for more diseases than I can count" said Margolis, "and these clinical trials means two things: First, thousands and thousands of human beings either have been treated, will be treated, or are being treated in these clinical trials by the only stem cells with a chance to improve their lives. Second, many powerful financial and investment leaders are spending hundreds of millions of dollars to fund these trials. They know that Repair Stem Cells are the future of medicine."

-- Margolis stated that "Embryonic Stem Cell (ESC) clinical trials are somewhere in the distant future, waiting for someone to discover an ESC which can be safely implanted into a human being." Six such attempts can be found at, but no treatments are even being considered.

Visit for RSCI's global listing of stem cell treatment centers and the doctors/researchers meeting the Institute's Standards of Excellence and are treating 100+ medical conditions.

About RSCI

The Repair Stem Cell Institute LLC (RSCI) is a global public service company dedicated to educating and informing the public about Repair Stem Cell research and treatments worldwide. RSCI was founded in April 2008 and is headquartered in Bangkok, Thailand with an administrative office in Dallas and its communications, government and political affairs office in Washington, D.C.

SOURCE Repair Stem Cell Institute LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
2. Excipients Help Pharma Extend Product Life, Profits
3. Early-Bird Registration Ends this Week for 10th Annual Quality Excellence Conference: How Process Improvement Leaders Produce Profits in Recessions
4. Aware Celebrates Fifteen Years of Innovation and Leadership in the Biometrics Industry
5. Social Network for Scientists Marks Ten Years Online
6. First New Class of Platinum-Based Chemotherapy Drug Candidates in 30 Years Demonstrate Ability to Kill Tumors Resistant to Currently Marketed Platinum Drugs
7. Dark energy -- 10 years on
8. Wyeth Consumer Healthcare Supports U.S. Food and Drug Administration Decision for Over-the-Counter Cough and Cold Medications in Children under Two Years of Age
9. Biotech Crops Experience Remarkable Dozen Years of Double-Digit Growth
10. Electrophysiology Procedures for Atrial Fibrillation Treatment to Grow Over 25% Annually Over the Next Five Years
11. Edwards Lifesciences Celebrates 50 Years of Life-Saving Innovations
Post Your Comments:
(Date:11/24/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: AEZ) ... of the Toronto Stock Exchange, confirms that as of ... corporate developments that would cause the recent movements in ... --> About Aeterna Zentaris Inc. ... Aeterna Zentaris is a specialty biopharmaceutical company engaged ...
(Date:11/24/2015)... PHILADELPIA, PA (PRWEB) , ... November 24, 2015 , ... ... young entrepreneurs at competitive events in five states to develop and pitch their BIG ... student projects from each state are competing for votes to win the title of ...
(Date:11/24/2015)... 2015 --> ... released by Transparency Market Research, the global non-invasive prenatal ... of 17.5% during the period between 2014 and 2022. ... Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast ... market to reach a valuation of US$2.38 bn by ...
(Date:11/24/2015)... FRANCISCO , Nov. 24, 2015  Twist ... announced that Emily Leproust, Ph.D., Twist Bioscience chief ... Jaffray Healthcare Conference on December 1, 2015 at ... Hotel in New York City. --> ... . Twist Bioscience is on Twitter. ...
Breaking Biology Technology:
(Date:10/29/2015)... , Oct. 29, 2015   MedNet Solutions ... the entire spectrum of clinical research, is pleased to ... High Tech Association (MHTA) as one of only three ... the "Software – Small and Growing" category. The Tekne Awards ... who have shown superior technology innovation and leadership. ...
(Date:10/29/2015)... 29, 2015  Rubicon Genomics, Inc., today announced ... of its DNA library preparation products, including the ... ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq has been optimized ... NGS libraries for liquid biopsies--the analysis of cell-free ... applications in cancer and other conditions. Eurofins Scientific ...
(Date:10/29/2015)... , Oct. 29, 2015 Today, ... a partnership with 2XU, a global leader in ... a smart hat with advanced bio-sensing technology. The ... athletes to monitor key biometrics to improve overall ... partnership, the two companies will bring together the most ...
Breaking Biology News(10 mins):